Intercept to Announce First Quarter 2018 Financial Results on May 8, 2018 and Present at Upcoming Investor Conferences

    NEXT STORY
    BeiGene Appoints Senior Pharmaceutical Executive Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.
    PREV STORY
    Immunovaccine Shareholders Approve Share Consolidation at 99.85%
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Basilea licenses late-stage oncology drug candidate derazantinib from ArQule

    author_avatar
    NASDAQ Market News

    Conferência de imprensa de quarta-feira da Conferência Mundial sobre Câncer de Pulmão: Aplicando as descobertas e os temas da conferência no mundo real

    TORONTO, Sept. 27, 2018 (GLOBE NEWSWIRE) -- A última coletiva de imprensa da 19ª ...

    author_avatar
    NASDAQ Market News

    Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate

    author_avatar
    NASDAQ Market News